Mutations and mechanisms of WNT pathway tumour suppressors in cancer - PubMed (original) (raw)

Review

Mutations and mechanisms of WNT pathway tumour suppressors in cancer

Jeroen M Bugter et al. Nat Rev Cancer. 2021 Jan.

Erratum in

• Publisher Correction: Mutations and mechanisms of WNT pathway tumour suppressors in cancer.
  Bugter JM, Fenderico N, Maurice MM. Bugter JM, et al. Nat Rev Cancer. 2021 Jan;21(1):64. doi: 10.1038/s41568-020-00316-y. Nat Rev Cancer. 2021. PMID: 33149279 No abstract available.

Abstract

Mutation-induced activation of WNT-β-catenin signalling is a frequent driver event in human cancer. Sustained WNT-β-catenin pathway activation endows cancer cells with sustained self-renewing growth properties and is associated with therapy resistance. In healthy adult stem cells, WNT pathway activity is carefully controlled by core pathway tumour suppressors as well as negative feedback regulators. Gene inactivation experiments in mouse models unequivocally demonstrated the relevance of WNT tumour suppressor loss-of-function mutations for cancer growth. However, in human cancer, a far more complex picture has emerged in which missense or truncating mutations mediate stable expression of mutant proteins, with distinct functional and phenotypic ramifications. Herein, we review recent advances and challenges in our understanding of how different mutational subsets of WNT tumour suppressor genes link to distinct cancer types, clinical outcomes and treatment strategies.

PubMed Disclaimer

Similar articles

• Targeting the Wnt/β-catenin signaling pathway in cancer.
  Zhang Y, Wang X. Zhang Y, et al. J Hematol Oncol. 2020 Dec 4;13(1):165. doi: 10.1186/s13045-020-00990-3. J Hematol Oncol. 2020. PMID: 33276800 Free PMC article. Review.
• [Screening for Chemical Suppressors of the Wnt/β-catenin Signaling Pathway].
  Nishiya N. Nishiya N. Yakugaku Zasshi. 2017;137(2):133-136. doi: 10.1248/yakushi.16-00229-2. Yakugaku Zasshi. 2017. PMID: 28154320 Review. Japanese.
• Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance.
  Wickström M, Dyberg C, Milosevic J, Einvik C, Calero R, Sveinbjörnsson B, Sandén E, Darabi A, Siesjö P, Kool M, Kogner P, Baryawno N, Johnsen JI. Wickström M, et al. Nat Commun. 2015 Nov 25;6:8904. doi: 10.1038/ncomms9904. Nat Commun. 2015. PMID: 26603103 Free PMC article.
• Wnt/beta-catenin pathway: modulating anticancer immune response.
  Pai SG, Carneiro BA, Mota JM, Costa R, Leite CA, Barroso-Sousa R, Kaplan JB, Chae YK, Giles FJ. Pai SG, et al. J Hematol Oncol. 2017 May 5;10(1):101. doi: 10.1186/s13045-017-0471-6. J Hematol Oncol. 2017. PMID: 28476164 Free PMC article. Review.
• Wnt signaling in cancer.
  Zhan T, Rindtorff N, Boutros M. Zhan T, et al. Oncogene. 2017 Mar;36(11):1461-1473. doi: 10.1038/onc.2016.304. Epub 2016 Sep 12. Oncogene. 2017. PMID: 27617575 Free PMC article. Review.

Cited by

• Genomic and transcriptional alterations in first-line chemotherapy exert a potentially unfavorable influence on subsequent immunotherapy in NSCLC.
  He Y, Chen L, Zhao L, Dang S, Liu G, Sasada S, Ma PC, van Zandwijk N, Rosell R, Popper HH, Wang H, Jiang M, Guo H, Liu X, Chen S, Zhang X, Xu M, Zhu B, Liu M, Zhou C. He Y, et al. Theranostics. 2021 May 13;11(14):7092-7109. doi: 10.7150/thno.58039. eCollection 2021. Theranostics. 2021. PMID: 34093873 Free PMC article.
• Turning cold tumors into hot tumors by improving T-cell infiltration.
  Liu YT, Sun ZJ. Liu YT, et al. Theranostics. 2021 Mar 11;11(11):5365-5386. doi: 10.7150/thno.58390. eCollection 2021. Theranostics. 2021. PMID: 33859752 Free PMC article. Review.
• Clone wars: From molecules to cell competition in intestinal stem cell homeostasis and disease.
  Colozza G, Park SY, Koo BK. Colozza G, et al. Exp Mol Med. 2022 Sep;54(9):1367-1378. doi: 10.1038/s12276-022-00854-5. Epub 2022 Sep 18. Exp Mol Med. 2022. PMID: 36117218 Free PMC article. Review.
• RNF43 Inactivation Enhances the B-RAF/MEK Signaling and Creates a Combinatory Therapeutic Target in Cancer Cells.
  Hsu SH, Tsai YL, Wang YT, Shen CH, Hung YH, Chen LT, Hung WC. Hsu SH, et al. Adv Sci (Weinh). 2024 Mar;11(12):e2304820. doi: 10.1002/advs.202304820. Epub 2024 Jan 15. Adv Sci (Weinh). 2024. PMID: 38225722 Free PMC article.
• Dvl2 facilitates the coordination of NF-κB and Wnt signaling to promote colitis-associated colorectal progression.
  Tang F, Cao F, Lu C, He X, Weng L, Sun L. Tang F, et al. Cancer Sci. 2022 Feb;113(2):565-575. doi: 10.1111/cas.15206. Epub 2021 Dec 15. Cancer Sci. 2022. PMID: 34807493 Free PMC article.

References

1. 1. Nusse, R. & Varmus, H. E. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 31, 99–109 (1982). - PubMed - DOI
2. 1. Nusse, R. & Varmus, H. Three decades of Wnts: a personal perspective on how a scientific field developed. EMBO J. 31, 2670–2684 (2012). - PubMed - PMC - DOI
3. 1. Korinek, V. et al. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat. Genet. 19, 379–383 (1998). - PubMed - DOI
4. 1. Huelsken, J., Vogel, R., Erdmann, B., Cotsarelis, G. & Birchmeier, W. β-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin. Cell 105, 533–545 (2001). - PubMed - DOI
5. 1. Pinto, D., Gregorieff, A., Begthel, H. & Clevers, H. Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. Genes Dev. 17, 1709–1713 (2003). - PubMed - PMC - DOI

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database